Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

156 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: a multicenter propensity score-matching study.
Kim S, Vendrely V, Saint A, André T, Vaflard P, Samalin E, Pernot S, Bouché O, Zubir M, Desrame J, de la Fouchardière C, Smith D, Ghiringhelli F, Vienot A, Jacquin M, Klajer E, Nguyen T, François É, Taieb J, Le Malicot K, Vernerey D, Meurisse A, Borg C. Kim S, et al. Among authors: de la fouchardiere c. Exp Hematol Oncol. 2023 Jul 21;12(1):63. doi: 10.1186/s40164-023-00413-2. Exp Hematol Oncol. 2023. PMID: 37480095 Free PMC article.
Stromal protein βig-h3 reprogrammes tumour microenvironment in pancreatic cancer.
Goehrig D, Nigri J, Samain R, Wu Z, Cappello P, Gabiane G, Zhang X, Zhao Y, Kim IS, Chanal M, Curto R, Hervieu V, de La Fouchardière C, Novelli F, Milani P, Tomasini R, Bousquet C, Bertolino P, Hennino A. Goehrig D, et al. Among authors: de la fouchardiere c. Gut. 2019 Apr;68(4):693-707. doi: 10.1136/gutjnl-2018-317570. Epub 2018 Nov 10. Gut. 2019. PMID: 30415234 Free PMC article.
Impact of clinical practice guidelines on the diagnostic strategy for carcinomas of unknown primary site: a controlled 'before-after' study.
Sève P, Mackey J, Sawyer M, Lesimple T, de la Fouchardière C, Broussolle C, Dumontet C, Ray-Coquard I. Sève P, et al. Among authors: de la fouchardiere c. Clin Oncol (R Coll Radiol). 2008 Oct;20(8):658-9. doi: 10.1016/j.clon.2008.06.003. Epub 2008 Jul 21. Clin Oncol (R Coll Radiol). 2008. PMID: 18644703 No abstract available.
Predictive factors of outcome in poorly differentiated thyroid carcinomas.
de la Fouchardière C, Decaussin-Petrucci M, Berthiller J, Descotes F, Lopez J, Lifante JC, Peix JL, Giraudet AL, Delahaye A, Masson S, Bournaud-Salinas C, Borson Chazot F. de la Fouchardière C, et al. Eur J Cancer. 2018 Mar;92:40-47. doi: 10.1016/j.ejca.2017.12.027. Epub 2018 Feb 3. Eur J Cancer. 2018. PMID: 29413688
An unusual presentation of pancreatic cancer: Muscular metastasis.
Belbarka R, Fadoukheir Z, Delafouchardiere C, Desseigne F, Errihani H. Belbarka R, et al. Indian J Cancer. 2014 July-September;51(3):369-370. doi: 10.4103/0019-509X.146714. Indian J Cancer. 2014. PMID: 25494141 Free article. No abstract available.
Targeted therapies and thyroid cancer: an update.
de la Fouchardiere C, Droz JP. de la Fouchardiere C, et al. Anticancer Drugs. 2011 Aug;22(7):688-99. doi: 10.1097/CAD.0b013e32834319c7. Anticancer Drugs. 2011. PMID: 21200314 Review.
156 results